Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Risk factors].

Yuko Kamikura1, Hideo Wada

  • 1Second Department of Internal Medicine, Department of Laboratory Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|October 28, 2003
PubMed
Summary

Pulmonary embolism (PE) risk increases with surgery, injury, and cancer. Evaluating acquired and congenital risk factors like abnormal proteins and thrombophilia is crucial for PE prevention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Usefulness of Clot Waveform Analysis-Activated Thromboplastin Time (APTT) for Diagnosing Thrombotic Diseases.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026
Same author

The C3 p.Ile1157Thr mutation associated with atypical hemolytic uremic syndrome, particularly in Japan, does not lead to disease development in several mouse models.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Recognizing Coagulation Disorders in Sepsis in the Emergency Room: A Narrative Review.

Journal of clinical medicine·2026
Same author

Evaluation of Autoimmune FVIII Inhibitor Using Clot Waveform Analysis in Emicizumab-Treated Patients.

Journal of clinical medicine·2026
Same author

Diagnostic and Prognostic Evaluation of Disseminated Intravascular Coagulation Using the Disseminated Intravascular Coagulation Index.

Journal of clinical medicine·2025
Same author

Factors influencing antithrombin activity following supplementation in sepsis-associated disseminated intravascular coagulation.

Thrombosis journal·2025

Area of Science:

  • Medical Science
  • Thrombosis Research
  • Pulmonary Medicine

Context:

  • Pulmonary embolism (PE) poses a significant risk following medical procedures, injuries, and in cancer patients.
  • Thrombosis risk factors include congenital conditions like Factor V Leiden and acquired factors such as cancer and antiphospholipid antibody syndrome.
  • Genetic predispositions to thrombosis differ between ethnic groups, with Caucasians more frequently exhibiting Factor V Leiden or abnormal FII, unlike Japanese populations.

Purpose:

  • To identify and evaluate key risk factors associated with pulmonary embolism (PE).
  • To differentiate between congenital and acquired risk factors for thrombosis.
  • To highlight the necessity of assessing these factors for effective PE prevention strategies.

Summary:

  • Surgical procedures, trauma, and cancer significantly elevate the risk of pulmonary embolism (PE).
  • Commonly observed thrombosis risk factors include deficiencies in proteins C and S, and abnormal antithrombin.
  • Congenital thrombophilias like Factor V Leiden and abnormal FII are prevalent in Caucasians but not typically in Japanese individuals.
  • Acquired risk factors for PE encompass cancer, hyperhomocysteinemia, dyslipidemia, and antiphospholipid antibody syndrome.

Impact:

  • Informing clinical practice for better patient risk stratification and PE prevention.
  • Guiding research towards targeted interventions for thrombosis based on risk factor profiles.
  • Improving patient outcomes by proactively managing PE risk factors.

Related Experiment Videos